Pulmonary Langerhans cell granulomatosis

Area of Science:

• Pulmonology
• Histiocytosis
• Immunology

Background:

• Pulmonary Langerhans cell granulomatosis (LCG), also known as histiocytosis X, is a rare lung disease.
• It is characterized by destructive granulomas predominantly affecting distal bronchioles, suggesting a possible classification as bronchiolitis.
• LCG typically affects young adult smokers, with multifocal or diffuse involvement seen more often in children.

Purpose of the Study:

• To review the diagnostic features and current understanding of pulmonary Langerhans cell granulomatosis.
• To explore the potential pathogenesis, including immune response and cellular origins.
• To highlight areas requiring further research, particularly regarding localized versus diffuse forms.

Main Methods:

• Review of characteristic lesions in pulmonary Langerhans cell granulomatosis.
• Analysis of diagnostic utility of high-resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL).
• Discussion of proposed pathogenetic mechanisms, including immune dysregulation and cellular clonality.

Main Results:

• High-resolution computed tomography (HRCT) is valuable for diagnosing pulmonary LCG by identifying characteristic cystic lesions and nodules.
• Bronchoalveolar lavage (BAL) offers diagnostic support in only a limited number of cases.
• Evidence suggests a possible role for an uncontrolled immune response involving Langerhans cells and granulocyte-macrophage colony-stimulating factor in adult LCG.

Conclusions:

• The pathogenesis of pulmonary LCG remains largely unknown, with ongoing debate about its origins.
• While clonal origin has been suggested in other histiocytosis forms, it is not yet established for pulmonary LCG.
• Further research is necessary to elucidate the distinct pathogenetic mechanisms in localized versus diffuse pulmonary LCG.